Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Monica AmatiLory Santarelli

Abstract

Improved detection methods for diagnosis of asymptomatic malignant mesothelioma (MM) are essential for an early and reliable detection and treatment of this type of neoplastic disease. Thus, focus has been on finding tumor markers in the blood that can be used for noninvasive detection of MM. Ninety-four asbestos-exposed subjects defined at high risk, 22 patients with MM, and 54 healthy subjects were recruited for evaluation of the clinical significance of 8-hydroxy-2'-deoxyguanosine (8OHdG) in WBCs and plasma concentrations of soluble mesothelin-related peptides (SMRPs), angiogenic factors [platelet-derived growth factor beta, hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor beta (VEGFbeta)], and matrix proteases [matrix metalloproteinase (MMP) 2, MMP9, tissue inhibitor of metalloproteinase (TIMP) 1, and TIMP2] for potential early detection of MM. The area under receiver operating characteristic (ROC) curves indicate that 8OHdG levels can discriminate asbestos-exposed subjects from healthy controls but not from MM patients. Significant area under ROC curve values were found for SMRPs, discriminating asbestos-exposed subjects from MM patients but not from healthy controls. Except ...Continue Reading

Citations

Jan 2, 2013·Medical Oncology·Rosa FilibertiFabio Spigno
May 7, 2009·Current Opinion in Pulmonary Medicine·Jenette Creaney, Bruce W S Robinson
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin HollevoetJan P van Meerbeeck
Apr 9, 2011·Biomarkers in Medicine·Alfonso CristaudoRudy Foddis
Jun 7, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alfonso CristaudoRudy Foddis
Feb 28, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Steven G GrayKenneth J O'Byrne
Mar 26, 2011·Pathology·Steven Chuan-Hao KaoSonja Klebe
Jul 22, 2008·Mutation Research·Monica AmatiLory Santarelli
Oct 4, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Lory SantarelliMarco Tomasetti
Oct 15, 2013·Statistics in Medicine·Jingjing Yin, Lili Tian
Oct 25, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Eun-Kee ParkDeborah H Yates
Feb 26, 2015·Mutagenesis·Sara StaffolaniLory Santarelli
Oct 5, 2016·Expert Review of Anticancer Therapy·Puey Ling ChiaThomas John
Jan 10, 2019·International Journal of Environmental Research and Public Health·Mariella CarrieriGiovanna Tranfo
Jun 7, 2019·Carcinogenesis·Christina N GillezeauEmanuela Taioli
Sep 20, 2011·The International Journal of Biological Markers·Nicola DipalmaLuigi Vimercati
Mar 22, 2014·Molecular and Clinical Oncology·Kazuya FukuokaTakashi Nakano
Apr 21, 2020·Archives of Environmental & Occupational Health·Elena SturchioSilvia Gioiosa
Jun 17, 2015·Oncotarget·Serena BenedettiRossella Galati
Jul 24, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Harvey I PassChandra M Goparaju
Oct 6, 2020·Thoracic Surgery Clinics·Harvey I PassChandra M Goparaju
Nov 19, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Eline SchillebeeckxKevin Lamote

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.